HEADER TRANSFERASE/INHIBITOR 12-APR-18 6D1Y TITLE CRYSTAL STRUCTURE OF TYROSINE-PROTEIN KINASE RECEPTOR IN COMPLEX WITH TITLE 2 2,4-DICHLORO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)BENZAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 5 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 6 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 7 P140-TRKA; COMPND 8 EC: 2.7.10.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: INSECT CELL EXPRESSION VECTOR PTIE1; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 266783; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PKRIC-N6 KEYWDS ALLOSTRIC INHIBITOR TYROSINE KINASE, TRANSFERASE, TRANSFERASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,E.JOHNSON,M.L.KRAUS,C.N.CRONIN REVDAT 3 13-MAR-24 6D1Y 1 REMARK REVDAT 2 01-MAY-19 6D1Y 1 JRNL REVDAT 1 02-MAY-18 6D1Y 0 JRNL AUTH S.K.BAGAL,K.OMOTO,D.C.BLAKEMORE,P.J.BUNGAY,J.G.BILSLAND, JRNL AUTH 2 P.J.CLARKE,M.S.CORBETT,C.N.CRONIN,J.J.CUI,R.DIAS, JRNL AUTH 3 N.J.FLANAGAN,S.E.GREASLEY,R.GRIMLEY,E.JOHNSON,D.FENGAS, JRNL AUTH 4 L.KITCHING,M.L.KRAUS,I.MCALPINE,A.NAGATA,G.J.WALDRON, JRNL AUTH 5 J.S.WARMUS JRNL TITL DISCOVERY OF ALLOSTERIC, POTENT, SUBTYPE SELECTIVE, AND JRNL TITL 2 PERIPHERALLY RESTRICTED TRKA KINASE INHIBITORS. JRNL REF J. MED. CHEM. V. 62 247 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 29672039 JRNL DOI 10.1021/ACS.JMEDCHEM.8B00280 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 66.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 24052 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1221 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.20 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2345 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1805 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2237 REMARK 3 BIN R VALUE (WORKING SET) : 0.1782 REMARK 3 BIN FREE R VALUE : 0.2286 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.61 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 108 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2383 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 154 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.37970 REMARK 3 B22 (A**2) : 4.48520 REMARK 3 B33 (A**2) : 1.89450 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.48180 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.150 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.149 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.143 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.862 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2489 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3382 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 848 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 398 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2489 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 302 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2890 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.51 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.54 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6D1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-APR-18. REMARK 100 THE DEPOSITION ID IS D_1000233873. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000000 REMARK 200 MONOCHROMATOR : ACCEL DCM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24069 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 66.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07900 REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.03800 REMARK 200 R SYM FOR SHELL (I) : 0.03800 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: WELL VOLUME: 25.0 UL WELL INGREDIENTS: REMARK 280 BUFFER: 0.1 M (5.0 UL OF STOCK 0.5 M) ADA (PH 6.50) SALT: 3.0 M REMARK 280 (9.375 UL OF STOCK 8.0 M) LITHIUM NITRATE PLATE SETUP REMARK 280 TEMPERATURE: 13 C PLATE INCUBATION TEMPERATURE: 4 C DROP VOLUME REMARK 280 FROM WELL: 0.1 UL DROP PROTEIN VOLUME: 0.1 UL PROTEIN REMARK 280 FORMULATION COMPOSITION: PROTEIN: (5.0 MG/ML) (0.14 MM) COMPOUND: REMARK 280 (3.00 MM), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 24.27550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 477 REMARK 465 SER A 478 REMARK 465 THR A 479 REMARK 465 GLU A 480 REMARK 465 PRO A 534 REMARK 465 GLU A 535 REMARK 465 GLN A 536 REMARK 465 LEU A 611 REMARK 465 ALA A 612 REMARK 465 GLY A 613 REMARK 465 GLY A 614 REMARK 465 GLU A 615 REMARK 465 ASP A 616 REMARK 465 VAL A 617 REMARK 465 ALA A 618 REMARK 465 PRO A 619 REMARK 465 VAL A 683 REMARK 465 GLY A 684 REMARK 465 GLY A 685 REMARK 465 ARG A 686 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 482 CG CD CE NZ REMARK 470 ASP A 537 CG OD1 OD2 REMARK 470 LYS A 538 CG CD CE NZ REMARK 470 LYS A 609 CG CD CE NZ REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 513 -61.05 -108.40 REMARK 500 GLU A 548 120.78 -31.07 REMARK 500 ARG A 649 -20.97 81.32 REMARK 500 ASP A 650 43.77 -140.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FQJ A 801 DBREF 6D1Y A 479 796 UNP P04629 NTRK1_HUMAN 381 698 SEQADV 6D1Y GLY A 477 UNP P04629 EXPRESSION TAG SEQADV 6D1Y SER A 478 UNP P04629 EXPRESSION TAG SEQRES 1 A 320 GLY SER THR GLU GLY LYS GLY SER GLY LEU GLN GLY HIS SEQRES 2 A 320 ILE ILE GLU ASN PRO GLN TYR PHE SER ASP ALA CYS VAL SEQRES 3 A 320 HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS TRP GLU SEQRES 4 A 320 LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU ALA GLU SEQRES 5 A 320 CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET LEU VAL SEQRES 6 A 320 ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER ALA ARG SEQRES 7 A 320 GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR MET LEU SEQRES 8 A 320 GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL CYS THR SEQRES 9 A 320 GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR MET ARG SEQRES 10 A 320 HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS GLY PRO SEQRES 11 A 320 ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL ALA PRO SEQRES 12 A 320 GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL ALA SER SEQRES 13 A 320 GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY LEU HIS SEQRES 14 A 320 PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS LEU VAL SEQRES 15 A 320 GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE GLY MET SEQRES 16 A 320 SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG VAL GLY SEQRES 17 A 320 GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO PRO GLU SEQRES 18 A 320 SER ILE LEU TYR ARG LYS PHE THR THR GLU SER ASP VAL SEQRES 19 A 320 TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE THR TYR SEQRES 20 A 320 GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR GLU ALA SEQRES 21 A 320 ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU ARG PRO SEQRES 22 A 320 ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET ARG GLY SEQRES 23 A 320 CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER ILE LYS SEQRES 24 A 320 ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN ALA PRO SEQRES 25 A 320 PRO VAL TYR LEU ASP VAL LEU GLY HET FQJ A 801 36 HETNAM FQJ 2,4-DICHLORO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL) HETNAM 2 FQJ BENZAMIDE FORMUL 2 FQJ C17 H13 CL2 N3 O FORMUL 3 HOH *154(H2 O) HELIX 1 AA1 SER A 484 ASN A 493 1 10 HELIX 2 AA2 LYS A 506 ARG A 508 5 3 HELIX 3 AA3 SER A 550 LEU A 567 1 18 HELIX 4 AA4 ASP A 596 HIS A 604 1 9 HELIX 5 AA5 GLY A 623 LEU A 644 1 22 HELIX 6 AA6 ALA A 652 ARG A 654 5 3 HELIX 7 AA7 GLN A 660 LEU A 662 5 3 HELIX 8 AA8 MET A 671 TYR A 676 1 6 HELIX 9 AA9 SER A 677 TYR A 680 5 4 HELIX 10 AB1 PRO A 690 MET A 694 5 5 HELIX 11 AB2 PRO A 695 ARG A 702 1 8 HELIX 12 AB3 THR A 705 THR A 722 1 18 HELIX 13 AB4 SER A 732 GLY A 743 1 12 HELIX 14 AB5 PRO A 753 TRP A 764 1 12 HELIX 15 AB6 GLU A 767 ARG A 771 5 5 HELIX 16 AB7 SER A 773 ALA A 787 1 15 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 GLY A 522 HIS A 530 -1 O VAL A 524 N LEU A 516 SHEET 3 AA1 5 LYS A 538 LEU A 546 -1 O VAL A 543 N PHE A 525 SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588 SHEET 1 AA2 2 CYS A 656 VAL A 658 0 SHEET 2 AA2 2 VAL A 664 ILE A 666 -1 O LYS A 665 N LEU A 657 CISPEP 1 ARG A 583 PRO A 584 0 -0.79 SITE 1 AC1 11 SER A 484 GLY A 485 LEU A 486 GLU A 560 SITE 2 AC1 11 ILE A 572 PHE A 646 HIS A 648 ASP A 668 SITE 3 AC1 11 PHE A 669 GLY A 670 HOH A 967 CRYST1 52.240 48.551 67.335 90.00 99.02 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019142 0.000000 0.003039 0.00000 SCALE2 0.000000 0.020597 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015037 0.00000